Stem cell transplantation for autoimmune diseases

Springer Seminars in Immunopathology - Tập 23 - Trang 193-213 - 2001
John Moore1, P. Brooks2
1Haematology Department, St. Vincents Hospital, Australia
2Faculty of Health Sciences, University of Queensland, Brisbane, Australia

Tóm tắt

HSCT in autoimmune diseases has now become one of the potential therapeutic options for physicians looking after patients with severe intractable autoimmune diseases. It has now progressed beyond theory based on animal and human case reports, but at this stage it has been appropriately reserved for patients with resistant disease in a clinical trial setting. Ongoing analysis of the safety and efficacy of patients in phase I/II trials will allow us to determine if there is a wider role for the procedure in diseases such as RA, SLE, SSc and MS. Meta-analyses of the data will enable appropriate selection of patients and the optimal transplant procedure, so that eventually randomised trials against gold standard therapy will become a reality. In the future, with a decreased morbidity and mortality from allogeneic transplantation, cure of these diseases is not an unrealistic option.

Tài liệu tham khảo

Atkinson K, Nivison-Smith I, Hawkins T (1997) Haemopoietic stem cell transplantation in Australia, 1992–95: A report from the Australian Bone Marrow Transplant Recipient Registry. Aust N Z J Med 27:408

Fassas A, Anagnostopoulos A, Giannaki C, Vadikolia C, Zambouli D, Papaioannou G (1998) Autologous blood stem cell therapy for autoimmune pancytopenia due to systemic lupus erythematosus. Bone Marrow Transplant 21 [Suppl 1]:53

Jondeau K, Job-Deslandre C, Bouscary D, Khanlou N, Menkes CJ, Dreyfus F (1997) Remission of nonerosive polyarthritis associated with Sjogren’s syndrome after autologous hematopoietic stem cell transplantation for lymphoma. J Rheumatol 24:2466

Ortmann RA, Klippel JH (2000) Update on cyclophosphamide for systemic lupus erythematosus. Rheum Dis Clin North Am 26:363

Roberts MM, To LB, Gillis D, Mundy J, Rawling C, Ng K, Juttner CA (1993) Immune reconstitution following peripheral blood stem cell transplantation, autologous bone marrow transplantation and al-logeneic bone marrow transplantation. Bone Marrow Transplant 12:469

Rosen O, Massenkeil G, Thiel A, Hiepe F, Haupl T, Burmester G, Gromnica-Ihle E, Radtke H, Radbruch A, Arnold R (1999) Autologous stem cell transplantation (ASCT) in refractory autoimmune disease: is early recovery of peripheral lymphocytes indicative of failure of immunoblation? Blood 94 [Suppl 1]: 355a

Traynor A, Cheng D, Stelka J, Rosa P, Schroeder J, Burt R (1999) Stem cell transplantation for severe systemic lupus is associated with sustained remission from disease and normalised Th1/Th2 activity. Blood 94 [Suppl l]:354a

Tugwell P, Pincus T, Yocum D, Stein M, Gluck O, Kraag G, McKendry R, Tesser J, Baker P, Wells G (1995) Combination therapy with cyclosporine and methotrexate in severe rheumatoid arthritis. The Methotrexate-Cyclosporine Combination Study Group. N Engl J Med 333:137

Vleiger A, Brinkman D, Quartier P, Prieur A, Cate R ten, Bierings M, Wulffraat N (1999) Macrophage activating syndrome: an unusual and fatal complication in 3 patients receiving autologous stem cell transplantation (ASCT) for refractory juvenile chronic arthritis. Blood 94 [Suppl 1]: 354a

Vleiger A, Wulffraat N, Kamphuis S, Sanders E, Kuis W (1999) Autologous stem cell transplantation in two patients with juvenile SLE. Blood 94 [Suppl 1]: 407b